Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Can Intermittent Fasting Help You Lose Weight And Provide Other Health Benefits?

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such as diabetes and heart disease.

Another study in the journal Cell Metabolism found that Intermittent Fasting can increase the production of a protein called brain-derived neurotrophic factor (BDNF), which is essential for the growth and maintenance of neurons in the brain.

Despite these promising findings, new research found that intermittent fasting may not be as beneficial for weight loss as previously thought while another study found that that it does not bring the same health benefits as other weight loss programs.

These new findings leave lots of questions unanswered. Does intermittent fasting help with weight loss and provide other health benefits or is it just another fad diet targeted to those who are looking to lose weight? Kimberly Gomer, director of nutrition at Body Beautiful Miami, is a leading nutritional expert in weight loss and medical nutrition for over 2 decades. She brings her years of experience to the discussion and offers her in-depth analysis of this dietary strategy.

Kim’s Thoughts:

I love this article on intermittent fasting because it brings to light an unknown idea for a lot of people. I do believe from the science, looking at the science, that there is benefit to time-restricted eating. So, you’re fasting for a certain amount of time and then you’re eating. The idea that immune autophagy maintaining muscle mass is a possibility with fasting.

But the exciting part for me as a nutritionist is the stability of blood sugar. Because high insulin levels, high blood sugars are a huge problem in the United States—we are looking at one in three people with prediabetes. We are looking at one in 10 people with diabetes, and we are looking at one in five people who don’t even know they have it.

So, this idea that we can lower insulin levels and we can stabilize blood sugar and do it through an intermittent fasting lifestyle, is amazing. And part of the science behind it is that when you are not eating, be it sleeping or just not eating, your insulin is very low. It’s the lowest when you’re not eating so allowing for a time that you are not eating in your day to be extended and eating only in a certain window, there are a lot of health benefits.

The problem that I see with some of these articles and understanding how they would apply to you as an individual is the fasting times are all over the place. Are you fasting for 18 hours a day? Are you fasting for 16 hours a day? Are you fasting for 12 hours a day?

Is your eating window very short? One to three hours or long eight hours. So, this idea of what is the best fasting and eating window is still not clear in some of the research, and more important in my mind, yes, intermittent fasting is a great tool. I use it in my private practice as a dietician with a lot of success.

But one thing that has to come with it is what are you eating? We live in a world of obesogenic food, highly processed, unhealthy food. So, some of my clients actually think, some people think well I can fast for 20 hours and for four hours I can go and eat fast food and eat junk, and I’m going to be healthy and thin. Not true.

So, I love intermittent fasting, I think we need more and more research about it. I think people need to be clear about what will work for them, how the tool can work for them as an individual, and more importantly, be clear about what they’re actually eating during their window. Again, I’m going to say I think that intermittent fasting is an awesome tool.

I’m so happy to see research being published. More research needs to be done and I think it can be very useful for a lot of people. Thank you.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512